![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication September 29, 2003.
Revised December 19, 2003.
Accepted for publication December 22, 2003.
ABSTRACT
To investigate the role of phospholipase C (PLC) in inflammatory processes, we tested U73122, a widely-employed PLC inhibitor, in several in vitro and in vivo assays. We first examined the effects of U73122 on human phospholipase C-
(PLC-
) isozymes and found that U73122 significantly inhibited recombinant human PLC-
2, with an IC50 of ~6 µM. U73122 had little effect on PLC-
1, PLC-
3, or PLC-
4. Consistent with its ability to inhibit PLC-
2 enzymatic activity, U73122 reduced interleukin-8 (IL-8) and leukotriene B4 (LTB4)-induced Ca2+-flux and chemotaxis in human neutrophils in a concentration-dependent manner. In vivo, U73122 blocked carrageenan-induced hind paw edema in rats, carrageenan-induced macrophage and lymphocyte accumulation into subcutaneous chambers in dogs, lipopolysaccharide (LPS)-induced macrophage, lymphocyte infiltration and PGE2 production in a mouse peritonitis model, and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear edema in mice. These results implicate PLC-dependent signaling pathways in the development of acute and chronic inflammatory responses in vivo.
Key words:
Inflammation, U73122, a phospholipase C inhibitor, macrophage infiltration, mouse ear edema, paw edema
This article has been cited by other articles:
![]() |
B. Fioravanti, M. De Felice, C. L. Stucky, K. A. Medler, M.-C. Luo, L. R. Gardell, M. Ibrahim, T. P. Malan Jr, H. I. Yamamura, M. H. Ossipov, et al. Constitutive Activity at the Cannabinoid CB1 Receptor Is Required for Behavioral Response to Noxious Chemical Stimulation of TRPV1: Antinociceptive Actions of CB1 Inverse Agonists J. Neurosci., November 5, 2008; 28(45): 11593 - 11602. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kolsch, P. G. Charest, and R. A. Firtel The regulation of cell motility and chemotaxis by phospholipid signaling J. Cell Sci., March 1, 2008; 121(5): 551 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Poeckel, L. Tausch, S. George, J. Jauch, and O. Werz 3-O-Acetyl-11-keto-boswellic Acid Decreases Basal Intracellular Ca2+ Levels and Inhibits Agonist-Induced Ca2+ Mobilization and Mitogen-Activated Protein Kinase Activation in Human Monocytic Cells J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 224 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Feisst, L. Franke, G. Appendino, and O. Werz Identification of Molecular Targets of the Oligomeric Nonprenylated Acylphloroglucinols from Myrtus communis and Their Implication as Anti-Inflammatory Compounds J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Feisst, D. Albert, D. Steinhilber, and O. Werz Mol. Pharmacol., May 1, 2005; 67(5): 1751 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Basset, F.-X. Boittin, O. M. Dorchies, J.-Y. Chatton, C. van Breemen, and U. T. Ruegg Involvement of Inositol 1,4,5-Trisphosphate in Nicotinic Calcium Responses in Dystrophic Myotubes Assessed by Near-plasma Membrane Calcium Measurement J. Biol. Chem., November 5, 2004; 279(45): 47092 - 47100. [Abstract] [Full Text] [PDF] |
||||